PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $243,000 | +39.7% | 48,219 | +77.8% | 0.05% | +62.5% |
| Q2 2015 | $174,000 | -8.9% | 27,123 | -0.1% | 0.03% | -11.1% |
| Q1 2015 | $191,000 | -79.2% | 27,141 | -77.2% | 0.04% | -79.8% |
| Q4 2014 | $920,000 | -29.2% | 119,271 | -23.8% | 0.18% | +19.5% |
| Q1 2014 | $1,300,000 | -2.6% | 156,556 | -1.1% | 0.15% | -7.5% |
| Q4 2013 | $1,335,000 | +5.7% | 158,256 | -0.2% | 0.16% | -0.6% |
| Q3 2013 | $1,263,000 | +3.2% | 158,556 | 0.0% | 0.16% | -3.6% |
| Q2 2013 | $1,224,000 | – | 158,556 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAYS ADVISORY LLC | 1,037,600 | $6,672,000 | 0.97% |
| Global X Management CO LLC | 2,435,411 | $15,660,000 | 0.86% |
| Advisors Asset Management, Inc. | 5,373,113 | $34,549,000 | 0.47% |
| Gotham Asset Management, LLC | 7,233,838 | $46,514,000 | 0.39% |
| TFS CAPITAL LLC | 582,438 | $3,745,000 | 0.37% |
| LOMBARDIA CAPITAL PARTNERS LLC | 1,637,611 | $10,530,000 | 0.36% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 95,122 | $611,634,000 | 0.33% |
| FIRST TRUST ADVISORS LP | 17,536,793 | $112,762,000 | 0.29% |
| Arrow Investment Advisors, LLC | 214,595 | $1,380,000 | 0.28% |
| GSA CAPITAL PARTNERS LLP | 954,853 | $6,140,000 | 0.24% |